Aggressive Angiomyxoma of the Cervix: A Unique Entity
Article Sidebar
Main Article Content
Abstract
Introduction: Aggressive angiomyxoma is a mesenchymal tumour which presents rarely; usually in women in reproductive age group, as a mass in the pelvic tissue. Only exceptionally, has it been seen to originate from the uterus and cervix.
Methods: We present a case of a 23-year-old woman who complained about abdominal pain and excessive vaginal bleeding three days after a spontaneous abortion. Examination revealed a large polyp arising from the cervix. Histopathologic examination of the polypectomy specimen revealed an aggressive angiomyxoma of the cervix. Immunohistochemistry was performed and the tumour was immunopositive for vimentin, desmin and smooth muscle actin. Management options are discussed, in light of need of fertility conservation.
Result: Aggressive angiomyxoma can originate from the mesenchymal tissue of the cervix.
Conclusions: Treatment may be individualized with surgery and hormonal treatment. Long term follow up is recommended.
Downloads
Article Details
Copyright (c) 2014 Siwatch S, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Steeper TA, Rosai J (1983) Aggressive angiomyxoma of the female pelvis and perineum. Report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm. Am J Surg Pathol 7: 463-475.
Chan YM, Hon E, Ngai SW, Ng TY, Wong LC (2000) Aggressive angiomyxoma in females: is radical resection the only option? Acta Obstet Gynecol Scand 79: 216-220.
Han-Geurts IJ, van Geel AN, van Doorn L, den Bakker M, Eggermont AM, et al. (2006) Aggressive angiomyxoma: multimodality treatments can avoid mutilating surgery. Eur J Surg Oncol 32: 1217-1221.
Behranwala KA, Thomas JM (2003) ‘Aggressive' angiomyxoma: a distinct clinical entity. Eur J Surg Oncol 29: 559-563.
Yaghoobian J, Zinn D, Ramanathan K, Pinck RL, Hilfer J (1987) Ultrasound and computed tomographic findings in aggressive angiomyxoma of the uterine cervix. JUM 6: 209-212.
Skálová A, Zámecník M, Michal M, Opatrny V (2000) Aggressive angiomyxoma presenting as polyp of uterine cavity. Pathol Res Pract 196: 719-725.
Bagga R, Keepanasseril A, Suri V, Nijhawan R (2007) Aggressive angiomyxoma of the vulva in pregnancy: a case report and review of management options. Med GenMed 9:16.
Zhang P, Song K, Li L, Geng F, Li J, et al. (2011) Aggressive angiomyxoma with massive ascites. Gynecol Oncol Case Rep 1: 12-13.
Laskin WB, Fetsch JF, Tavassoli FA (2001) Superficial cervicovaginal myofibroblastoma: fourteen cases of a distinctive mesenchymal tumor arising from the specialized subepithelial stroma of the lower female genital tract. Hum Pathol 32: 715-725.
Layfield LJ, Dodd LG (1997) Fine-needle aspiration cytology findings in a case of aggressive angiomyxoma: a case report and review of the literature. Diagn Cytopathol 16: 425-429.
Haldar K, Martinek IE, Kehoe S (2010) Aggressive angiomyxoma: a case series and literature review. Eur J Surg Oncol 36: 335-339.
Tsarpalis DC, Giannakopoulos CK, Lagadas AA, Toufexi EG (2007) Aggressive angiomyxoma: case report and review of the literature. Eur J Gynaecol Oncol 28: 480-482.
Lee CW, Yoon JH, Park DC, Lee SJ (2011) Aggressive angiomyxoma of the vulva treated by using a gonadotropin-releasing hormone agonist: a case report. Eur J Gynaecol Oncol 32: 686-688.
Poirier M, Fraser R, Meterissian S (2003) Case 1. Aggressive angiomyxoma of the pelvis: response to luteinizing hormone-releasing hormone agonist. J Clin Oncol 21: 3535-3536.
Rhomberg W, Jasarevic Z, Alton R, Kompatscher P, Beer G, et al. (2000) Aggressive angiomyxoma: irradiation for recurrent disease. Strahlenther Onkol 176: 324-326.
Coppola S, Desai A, Tzanis D, Honoré C, Bitsakou G, et al. (2013) Conservative en bloc surgery for aggressive angiomyxoma achieves good local control: analysis of 14 patients from a single institution. Int J Gynecol Cancer 23: 540-545.
Bai HM, Yang JX, Huang HF, Cao DY, Chen J, et al. (2013) Individualized managing strategies of aggressive angiomyxoma of female genital tract and pelvis. Eur J Surg Oncol 39: 1101-1108.